SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-064924
Filing Date
2018-10-31
Accepted
2018-10-31 08:54:25
Documents
9
Period of Report
2018-10-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-38168_18k.htm 8-K 87418
2 EX-2.1 a18-38168_1ex2d1.htm EX-2.1 1578798
3 EX-10.1 a18-38168_1ex10d1.htm EX-10.1 160711
4 EX-10.2 a18-38168_1ex10d2.htm EX-10.2 63176
5 EX-10.3 a18-38168_1ex10d3.htm EX-10.3 70666
6 EX-99.1 a18-38168_1ex99d1.htm EX-99.1 617736
7 EX-99.2 a18-38168_1ex99d2.htm EX-99.2 1305375
8 EX-99.3 a18-38168_1ex99d3.htm EX-99.3 20806
9 GRAPHIC g381681mqi001.jpg GRAPHIC 2923
  Complete submission text file 0001104659-18-064924.txt   3910464
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Egalet Corp (Filer) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36295 | Film No.: 181148808
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences